CryoPort (CYRX) Receiving Somewhat Positive Press Coverage, Study Shows

News articles about CryoPort (NASDAQ:CYRX) have been trending somewhat positive on Friday, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. CryoPort earned a coverage optimism score of 0.17 on Accern’s scale. Accern also assigned headlines about the consumer goods maker an impact score of 44.9235280273274 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Shares of NASDAQ CYRX traded down $0.06 during midday trading on Friday, hitting $8.32. The stock had a trading volume of 33,141 shares, compared to its average volume of 125,318. The firm has a market capitalization of $230.03, a P/E ratio of -24.47 and a beta of 0.66. CryoPort has a 1-year low of $2.19 and a 1-year high of $10.40.

CryoPort (NASDAQ:CYRX) last released its quarterly earnings data on Tuesday, March 6th. The consumer goods maker reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.02). The firm had revenue of $3.33 million during the quarter, compared to analyst estimates of $3.37 million. CryoPort had a negative net margin of 66.09% and a negative return on equity of 47.36%. The firm’s quarterly revenue was up 49.5% on a year-over-year basis. equities analysts expect that CryoPort will post -0.29 earnings per share for the current fiscal year.



A number of analysts have issued reports on CYRX shares. Needham & Company LLC reissued a “buy” rating and issued a $11.00 price target (up from $10.00) on shares of CryoPort in a research note on Thursday, March 8th. BidaskClub raised CryoPort from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, March 21st. Finally, ValuEngine raised CryoPort from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Six analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and an average target price of $33.70.

In other news, CEO Jerrell Shelton sold 29,257 shares of CryoPort stock in a transaction dated Tuesday, March 13th. The stock was sold at an average price of $9.83, for a total value of $287,596.31. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 9.00% of the company’s stock.

TRADEMARK VIOLATION WARNING: “CryoPort (CYRX) Receiving Somewhat Positive Press Coverage, Study Shows” was originally posted by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://dakotafinancialnews.com/2018/04/13/cryoport-cyrx-receiving-somewhat-positive-press-coverage-study-shows.html.

CryoPort Company Profile

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Insider Buying and Selling by Quarter for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply